SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '11N'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AQ7_B_AG2B4_1 (TRYPSINAERUGINOSIN 98-B) |
2zec | TRYPTASE BETA 2 (Homosapiens) | 7 / 8 | HIS A 59ASP A 203SER A 204SER A 209VAL A 227GLY A 230GLY A 240 | None11N A 1 (-2.6A)11N A 1 (-3.5A)11N A 1 (-3.3A)None11N A 1 (-3.9A)11N A 1 (-3.6A) | 0.50A | 1aq7A-2zecA:32.4 | 1aq7A-2zecA:40.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1BCU_H_PRLH280_0 (ALPHA-THROMBIN) |
2zec | TRYPTASE BETA 2 (Homosapiens) | 6 / 9 | ASP A 203SER A 209VAL A 227TRP A 229GLY A 230GLY A 240 | 11N A 1 (-2.6A)11N A 1 (-3.3A)NoneNone11N A 1 (-3.9A)11N A 1 (-3.6A) | 0.52A | 1bcuH-2zecA:33.7 | 1bcuH-2zecA:35.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1DWC_H_MITH1_1 (ALPHA-THROMBIN(LARGE SUBUNIT)) |
2zec | TRYPTASE BETA 2 (Homosapiens) | 5 / 9 | HIS A 59ASP A 203SER A 209TRP A 229GLY A 240 | None11N A 1 (-2.6A)11N A 1 (-3.3A)None11N A 1 (-3.6A) | 0.43A | 1dwcH-2zecA:33.2 | 1dwcH-2zecA:35.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ETR_H_MITH1_1 (EPSILON-THROMBIN) |
2zec | TRYPTASE BETA 2 (Homosapiens) | 7 / 12 | HIS A 59ASP A 203SER A 209VAL A 227TRP A 229GLY A 230GLY A 240 | None11N A 1 (-2.6A)11N A 1 (-3.3A)NoneNone11N A 1 (-3.9A)11N A 1 (-3.6A) | 0.55A | 1etrH-2zecA:33.3 | 1etrH-2zecA:36.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1F5L_A_AMRA301_1 (UROKINASE-TYPEPLASMINOGENACTIVATOR) |
2zec | TRYPTASE BETA 2 (Homosapiens) | 7 / 8 | ASP A 203SER A 204GLN A 206SER A 209VAL A 227GLY A 230GLY A 240 | 11N A 1 (-2.6A)11N A 1 (-3.5A)None11N A 1 (-3.3A)None11N A 1 (-3.9A)11N A 1 (-3.6A) | 0.43A | 1f5lA-2zecA:34.0 | 1f5lA-2zecA:35.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RQP_B_SAMB500_1 (5'-FLUORO-5'-DEOXYADENOSINE SYNTHASE) |
2zec | TRYPTASE BETA 2 (Homosapiens) | 4 / 8 | ASP A 106PHE A 98SER A 209ALA A 108 | NoneNone11N A 1 (-3.3A)None | 1.05A | 1rqpC-2zecA:undetectable | 1rqpC-2zecA:21.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RQP_C_SAMC500_0 (5'-FLUORO-5'-DEOXYADENOSINE SYNTHASE) |
2zec | TRYPTASE BETA 2 (Homosapiens) | 4 / 8 | ASP A 106PHE A 98SER A 209ALA A 108 | NoneNone11N A 1 (-3.3A)None | 1.04A | 1rqpA-2zecA:undetectable | 1rqpA-2zecA:21.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TNL_A_TPAA900_1 (TRYPSIN) |
2zec | TRYPTASE BETA 2 (Homosapiens) | 6 / 6 | ASP A 203SER A 204SER A 209VAL A 227GLY A 230GLY A 240 | 11N A 1 (-2.6A)11N A 1 (-3.5A)11N A 1 (-3.3A)None11N A 1 (-3.9A)11N A 1 (-3.6A) | 0.36A | 1tnlA-2zecA:32.7 | 1tnlA-2zecA:40.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OTV_A_NCAA1301_0 (CATIONIC TRYPSIN) |
2zec | TRYPTASE BETA 2 (Homosapiens) | 6 / 6 | ASP A 203SER A 204SER A 209VAL A 227GLY A 230GLY A 240 | 11N A 1 (-2.6A)11N A 1 (-3.5A)11N A 1 (-3.3A)None11N A 1 (-3.9A)11N A 1 (-3.6A) | 0.36A | 2otvA-2zecA:32.9 | 2otvA-2zecA:40.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2P16_A_GG2A298_1 (COAGULATION FACTOR X(EC 3.4.21.6)(STUART FACTOR)(STUART-PROWERFACTOR)) |
2zec | TRYPTASE BETA 2 (Homosapiens) | 7 / 12 | ASP A 203SER A 209VAL A 227TRP A 229GLY A 230GLY A 240TYR A 242 | 11N A 1 (-2.6A)11N A 1 (-3.3A)NoneNone11N A 1 (-3.9A)11N A 1 (-3.6A)None | 0.38A | 2p16A-2zecA:32.9 | 2p16A-2zecA:34.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2VIN_A_505A1247_1 (UROKINASE-TYPEPLASMINOGENACTIVATOR CHAIN B) |
2zec | TRYPTASE BETA 2 (Homosapiens) | 7 / 8 | ASP A 203SER A 204GLN A 206SER A 209VAL A 227GLY A 230GLY A 240 | 11N A 1 (-2.6A)11N A 1 (-3.5A)None11N A 1 (-3.3A)None11N A 1 (-3.9A)11N A 1 (-3.6A) | 0.36A | 2vinA-2zecA:34.4 | 2vinA-2zecA:35.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W26_A_RIVA1001_1 (ACTIVATED FACTOR XAHEAVY CHAIN) |
2zec | TRYPTASE BETA 2 (Homosapiens) | 8 / 12 | ASP A 203SER A 209VAL A 227TRP A 229GLY A 230GLY A 232GLY A 240TYR A 242 | 11N A 1 (-2.6A)11N A 1 (-3.3A)NoneNone11N A 1 (-3.9A)11N A 1 (-3.8A)11N A 1 (-3.6A)None | 0.47A | 2w26A-2zecA:32.9 | 2w26A-2zecA:34.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GY3_A_PNTA246_0 (CATIONIC TRYPSIN) |
2zec | TRYPTASE BETA 2 (Homosapiens) | 7 / 11 | HIS A 59ASP A 203SER A 204SER A 209TRP A 229GLY A 230GLY A 240 | None11N A 1 (-2.6A)11N A 1 (-3.5A)11N A 1 (-3.3A)None11N A 1 (-3.9A)11N A 1 (-3.6A) | 0.33A | 3gy3A-2zecA:12.7 | 3gy3A-2zecA:40.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3I5U_B_SAMB401_0 (O-METHYLTRANSFERASE) |
2zec | TRYPTASE BETA 2 (Homosapiens) | 5 / 12 | LEU A 110GLY A 45GLY A 46SER A 204ASP A 106 | NoneNoneNone11N A 1 (-3.5A)None | 1.09A | 3i5uB-2zecA:undetectable | 3i5uB-2zecA:20.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RXF_A_4APA9_1 (CATIONIC TRYPSIN) |
2zec | TRYPTASE BETA 2 (Homosapiens) | 6 / 6 | SER A 204SER A 209VAL A 227TRP A 229GLY A 230GLY A 240 | 11N A 1 (-3.5A)11N A 1 (-3.3A)NoneNone11N A 1 (-3.9A)11N A 1 (-3.6A) | 0.41A | 3rxfA-2zecA:13.5 | 3rxfA-2zecA:40.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RXH_A_HSMA7_1 (CATIONIC TRYPSIN) |
2zec | TRYPTASE BETA 2 (Homosapiens) | 5 / 5 | ASP A 203SER A 204SER A 209VAL A 227GLY A 240 | 11N A 1 (-2.6A)11N A 1 (-3.5A)11N A 1 (-3.3A)None11N A 1 (-3.6A) | 0.35A | 3rxhA-2zecA:32.8 | 3rxhA-2zecA:40.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FU8_A_ACTA302_0 (UROKINASE-TYPEPLASMINOGENACTIVATOR) |
2zec | TRYPTASE BETA 2 (Homosapiens) | 4 / 5 | HIS A 59GLN A 206GLY A 207SER A 209 | NoneNoneNone11N A 1 (-3.3A) | 0.32A | 4fu8A-2zecA:34.2 | 4fu8A-2zecA:35.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4HFP_D_15UD402_1 (PROTHROMBIN) |
2zec | TRYPTASE BETA 2 (Homosapiens) | 5 / 12 | HIS A 59ASP A 203VAL A 227TRP A 229GLY A 240 | None11N A 1 (-2.6A)NoneNone11N A 1 (-3.6A) | 0.37A | 4hfpD-2zecA:33.1 | 4hfpD-2zecA:35.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RN6_B_15UB301_1 (THROMBIN HEAVY CHAIN) |
2zec | TRYPTASE BETA 2 (Homosapiens) | 5 / 12 | HIS A 59VAL A 227TRP A 229GLY A 230GLY A 240 | NoneNoneNone11N A 1 (-3.9A)11N A 1 (-3.6A) | 0.48A | 4rn6B-2zecA:28.0 | 4rn6B-2zecA:35.32 |